On page 25 of the Challenge Brief, when talking about FR10.1 - "Incorporation of patient held devices", you say: "In relation to devices for monitoring, suppliers will be required to consider innovations from the HSMonitor PCP.".Could you please specify which innovations you refer to? To our knowledge the results of HSMonitor are not in the public domain, are they?

On page 25 of the Challenge Brief, when talking about FR10.1 - "Incorporation of patient held devices", you say: "In relation to devices for monitoring, suppliers will be required to consider innovations from the HSMonitor PCP.". Could you please specify which innovations you refer to? To our knowledge the results of HSMonitor are not in the public domain, are they?

For the time being, information obtained from the website and the websites of the suppliers of Phase III should be sufficient. Updates on Phase III of HSMonitor are expected to be available online in the first half of March 2022.

Question number:

00-29

Date:

February 14, 2022

Asked via:

Last updated:

March 1, 2022

Scope document for the OMC

If you would like to better understand what is expected in INCAREHEART have a look at this detailed description of the building blocks and use cases. Please note that this is draft information with the purpose of consulting the market and that it might differ from the final versions included in the Call for Tenders.

OMC Questionnaire

The OMC questionnaire aims to obtain market feedback on the planned PCP and assess existing solutions. The collected input will inform the ongoing tender specifications development. Let us know what you think before the 31st of August 2021.

If you are searching partners for a joint tender and would like to appear on the Matchmaking section of this website, you can register by completing the OMC questionnaire. This part of the questionnaire will remain open until the closure of the Call for Tenders.

Scope document for the OMC

OMC Questionnaire

The INCAREHEART PCP

© 2021 empirica. All rights reserved. Incareheart has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 965134.